These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11099903)

  • 1. Non-transferrin-bound iron, iron-related oxidative stress and lipid peroxidation in beta-thalassemia intermedia.
    Domenica Cappellini M; Tavazzi D; Duca L; Marelli S; Fiorelli G
    Transfus Sci; 2000 Dec; 23(3):245-6. PubMed ID: 11099903
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipid peroxidation and antioxidant status in beta-thalassemia.
    Meral A; Tuncel P; Sürmen-Gür E; Ozbek R; Oztürk E; Günay U
    Pediatr Hematol Oncol; 2000 Dec; 17(8):687-93. PubMed ID: 11127401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron status and oxidative stress in beta-thalassemia patients in Jakarta.
    Laksmitawati DR; Handayani S; Udyaningsih-Freisleben SK; Kurniati V; Adhiyanto C; Hidayat J; Kusnandar S; Dillon HS; Munthe BG; Wirawan R; Soegianto RR; Ramelan W; Freisleben HJ
    Biofactors; 2003; 19(1-2):53-62. PubMed ID: 14757977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane-bound iron contributes to oxidative damage of beta-thalassaemia intermedia erythrocytes.
    Tavazzi D; Duca L; Graziadei G; Comino A; Fiorelli G; Cappellini MD
    Br J Haematol; 2001 Jan; 112(1):48-50. PubMed ID: 11167782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Green tea extract modulates oxidative tissue injury in beta-thalassemic mice by chelation of redox iron and inhibition of lipid peroxidation.
    Koonyosying P; Kongkarnka S; Uthaipibull C; Svasti S; Fucharoen S; Srichairatanakool S
    Biomed Pharmacother; 2018 Dec; 108():1694-1702. PubMed ID: 30372872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative determination of ortho- and meta-tyrosine as biomarkers of protein oxidative damage in beta-thalassemia.
    Matayatsuk C; Poljak A; Bustamante S; Smythe GA; Kalpravidh RW; Sirankapracha P; Fucharoen S; Wilairat P
    Redox Rep; 2007; 12(5):219-28. PubMed ID: 17925094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The reduction of cholesteryl linoleate in lipoproteins: an index of clinical severity in beta-thalassemia/Hb E.
    Luechapudiporn R; Morales NP; Fucharoen S; Chantharaksri U
    Clin Chem Lab Med; 2006; 44(5):574-81. PubMed ID: 16681427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of cardiac iron loading and dysfunction in thalassemic mice by curcuminoids.
    Thephinlap C; Phisalaphong C; Lailerd N; Chattipakorn N; Winichagoon P; Vadolas J; Fucharoen S; Porter JB; Srichairatanakool S
    Med Chem; 2011 Jan; 7(1):62-9. PubMed ID: 21235521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood antioxidant status and urinary levels of catecholamine metabolites in beta-thalassemia.
    De Luca C; Filosa A; Grandinetti M; Maggio F; Lamba M; Passi S
    Free Radic Res; 1999 Jun; 30(6):453-62. PubMed ID: 10400457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative status and malondialdehyde in beta-thalassaemia patients.
    Cighetti G; Duca L; Bortone L; Sala S; Nava I; Fiorelli G; Cappellini MD
    Eur J Clin Invest; 2002 Mar; 32 Suppl 1():55-60. PubMed ID: 11886433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for a proatherogenic biochemical phenotype in beta thalassemia minor and intermedia.
    Lai ME; Vacquer S; Carta MP; Spiga A; Cocco P; Abete C; Dessì S; Mandas A
    Acta Haematol; 2011; 126(2):87-94. PubMed ID: 21576933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of curcuminoids in alleviation of iron overload and lipid peroxidation in thalassemic mice.
    Thephinlap C; Phisalaphong C; Fucharoen S; Porter JB; Srichairatanakool S
    Med Chem; 2009 Sep; 5(5):474-82. PubMed ID: 19534681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reevaluation of iron absorption and serum ferritin in beta-thalassemia intermedia.
    Gümrük F; Gürgey A; Duru F; Altay C
    Pediatr Hematol Oncol; 1992; 9(4):359-63. PubMed ID: 1467169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thalassemia intermedia is associated with a proatherogenic biochemical phenotype.
    Lai ME; Vacquer S; Carta MP; Spiga A; Cocco P; Angius F; Mandas A; Dessì S
    Blood Cells Mol Dis; 2011 Apr; 46(4):294-9. PubMed ID: 21402483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver iron concentrations and urinary hepcidin in beta-thalassemia.
    Origa R; Galanello R; Ganz T; Giagu N; Maccioni L; Faa G; Nemeth E
    Haematologica; 2007 May; 92(5):583-8. PubMed ID: 17488680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of serum ferritin and iron burden by intake of antioxidants in beta thalassemia major.
    Bhagat SS; Sarkar PD; Suryakar AN; Padalkar RK; Ghone RA; Patil SM; Hundekar PS
    Indian J Physiol Pharmacol; 2013; 57(2):189-94. PubMed ID: 24617170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disturbances of biomarkers of iron and oxidant-antioxidant homeostasis in patients with beta-thalassemia intermedia.
    Kattamis C; Lazaropoulou C; Delaporta P; Apostolakou F; Kattamis A; Papassotiriou I
    Pediatr Endocrinol Rev; 2011 Mar; 8 Suppl 2():256-62. PubMed ID: 21705975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress in patients with beta-thalassemia major.
    Pavlova LE; Savov VM; Petkov HG; Charova IP
    Prilozi; 2007 Jul; 28(1):145-54. PubMed ID: 17921925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second international round robin for the quantification of serum non-transferrin-bound iron and labile plasma iron in patients with iron-overload disorders.
    de Swart L; Hendriks JC; van der Vorm LN; Cabantchik ZI; Evans PJ; Hod EA; Brittenham GM; Furman Y; Wojczyk B; Janssen MC; Porter JB; Mattijssen VE; Biemond BJ; MacKenzie MA; Origa R; Galanello R; Hider RC; Swinkels DW
    Haematologica; 2016 Jan; 101(1):38-45. PubMed ID: 26385212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of iron overload on endocrinopathies in patients with beta-thalassaemia major and intermedia.
    Kurtoglu AU; Kurtoglu E; Temizkan AK
    Endokrynol Pol; 2012; 63(4):260-3. PubMed ID: 22933160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.